Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Taro Pharm Inds
(NY:
TARO
)
42.48
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Apr 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
42.48
Bid (Size)
41.50 (1)
Ask (Size)
45.00 (1)
Prev. Close
42.48
Today's Range
42.48 - 42.48
52wk Range
24.69 - 45.76
Shares Outstanding
37,584,631
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
TARO PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Taro Pharmaceutical Industries Ltd. - TARO
April 22, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
April 15, 2024
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
Performance
YTD
+1.72%
+1.72%
1 Month
+0.81%
+0.81%
3 Month
-1.96%
-1.96%
6 Month
+26.65%
+26.65%
1 Year
+67.97%
+67.97%
More News
Read More
TARO PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Taro Pharmaceutical Industries Ltd. - TARO
February 06, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
Earnings Preview For Taro Pharmaceutical Indus
January 24, 2024
Via
Benzinga
Taro Pharmaceutical Indus Earnings Preview
October 25, 2023
Via
Benzinga
Why Shares of Taro Pharmaceutical Are Rising Tuesday
May 30, 2023
Via
The Motley Fool
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Rover Group, Inc. (Nasdaq - ROVR), M.D.C. Holdings, Inc. (NYSE - MDC), Taro Pharmaceutical Industries Ltd. (NYSE - TARO), PGT Innovations Inc. (NYSE - PGTI)
January 26, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
Taro Provides Results for December 31, 2023
January 25, 2024
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Rover Group, Inc. (Nasdaq - ROVR), M.D.C. Holdings, Inc. (NYSE - MDC), Taro Pharmaceutical Industries Ltd. (NYSE - TARO), PGT Innovations Inc. (NYSE - PGTI)
January 22, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Wednesday
March 15, 2023
Via
Benzinga
Earnings Scheduled For January 25, 2024
January 25, 2024
Via
Benzinga
Taro to Release Third Quarter Results on January 25, 2024
January 19, 2024
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: M.D.C. Holdings, Inc. (NYSE - MDC), Cornerstone Financial Corporation (OTC - CFIC), Taro Pharmaceutical Industries Ltd. (NYSE - TARO), PGT Innovations Inc. (NYSE -
January 18, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
TARO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Taro Pharmaceutical Industries Ltd. Is Fair to Shareholders
January 17, 2024
From
Halper Sadeh LLC
Via
Business Wire
Taro Provides Results for September 30, 2023
October 26, 2023
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
Earnings Scheduled For October 26, 2023
October 26, 2023
Via
Benzinga
Taro to Release Second Quarter Results on October 26, 2023
October 19, 2023
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
Taro Provides Results for the Quarter Ended June 30, 2023
July 26, 2023
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
Taro to Release First Quarter Results on July 26, 2023
July 19, 2023
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2023
June 30, 2023
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) Near the Top of Equities by Percentage Gain on 5/30
May 30, 2023
Via
Investor Brand Network
Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 30, 2023
Via
Benzinga
Taro Provides Results for Year Ended March 31, 2023
May 23, 2023
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
Taro to Release Full Year Results on May 23, 2023
May 18, 2023
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
Taro Provides Results for December 31, 2022
January 24, 2023
From
Taro Pharmaceutical Industries Ltd.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
